Procore (PCOR) CFO Designate receives 152,318-share RSU equity grant
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Pyles Rachel reported acquisition or exercise transactions in this Form 4 filing.
PROCORE TECHNOLOGIES, INC. CFO Designate Rachel Pyles received a grant of 152,318 shares of common stock in the form of restricted stock units. These RSUs carry no purchase price and represent equity-based compensation rather than an open-market transaction.
According to the vesting terms, one-fourth of the RSUs will vest on the first anniversary of the vesting commencement date, with the remaining RSUs vesting in equal quarterly installments on each February 20, May 20, August 20, and November 20, subject to her continued service. Following this grant, Pyles holds 152,318 shares directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Pyles Rachel
Role
CFO Designate
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 152,318 | $0.00 | -- |
Holdings After Transaction:
Common Stock — 152,318 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What insider transaction did PROCORE TECHNOLOGIES (PCOR) report for Rachel Pyles?
PROCORE TECHNOLOGIES reported that CFO Designate Rachel Pyles received 152,318 restricted stock units as equity compensation. The Form 4 shows this as an acquisition, not a market purchase, reflecting a stock grant that increases her direct ownership stake in the company.
Is Rachel Pyles’ PROCORE TECHNOLOGIES (PCOR) equity grant an open-market buy?
No, the 152,318 shares reported for Rachel Pyles are a restricted stock unit grant with a zero dollar price per share. It is compensation awarded by the company, not an open-market purchase, and therefore does not reflect cash spent to buy stock in the market.
What is the vesting schedule for Rachel Pyles’ PROCORE TECHNOLOGIES (PCOR) RSUs?
One-fourth of Rachel Pyles’ RSUs will vest on the first anniversary of the vesting commencement date. The remaining three-fourths vest in equal quarterly installments on February 20, May 20, August 20, and November 20, conditioned on her continued service with PROCORE TECHNOLOGIES.
What role does Rachel Pyles hold at PROCORE TECHNOLOGIES (PCOR) in this Form 4?
In this Form 4, Rachel Pyles is identified as the CFO Designate of PROCORE TECHNOLOGIES. The reported 152,318-share restricted stock unit grant aligns with her executive role and is structured as equity compensation rather than a typical trading transaction in the company’s stock.